Faculty

Andrew M. Intlekofer, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Andrew Intlekofer investigates why cancer cells depend on specific pathways of nutrient metabolism.

Andrew Intlekofer Lab Group

Christine A. Iacobuzio-Donahue, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Christine Iacobuzio-Donahue studies the genomics and cell biology of pancreatic and other solid tumors as it relates to subclonal evolution, tumor progression, and metastasis.

The Christine Iacobuzio-Donahue Lab

David B. Solit, MD

Human Oncology & Pathogenesis Program

Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.

The David Solit Lab

Emily H. Cheng, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Emily Cheng focuses on the molecular mechanisms of cell death and their implications in tumorigenesis and cancer therapy, with primary emphasis on lung and kidney cancers.

The Cheng Lab

Ingo K. Mellinghoff, MD

Human Oncology & Pathogenesis Program

Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.

The Ingo Mellinghoff Lab

James A. Fagin, MD

Human Oncology & Pathogenesis Program

Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.

The James Fagin Lab

Jorge S. Reis-Filho, MD, PhD

Human Oncology & Pathogenesis Program

Physician-scientist Jorge Reis-Filho focuses on the development of a predictive molecular classification for rare types of breast cancer and characterization of intratumor genetic heterogeneity in breast cancers.

The Jorge Reis-Filho Lab